Cardinal Health Q1 GAAP EPS $1.70; Non-GAAP EPS $1.88, up 9% YoY; Raises FY25 guidance

CARDINAL HEALTH INC

2025-Q1 EPS reported $1.70 revenue$52,277,000,000

Revenue $52.3B, down 4% (up 15% ex-large customer expiration); Pharmaceutical segment profit up 16% to $530M.
Non-GAAP operating earnings $625M (+12%) driven by brand/specialty growth and early COVID vaccine distribution.
Non-GAAP diluted EPS guidance raised to $7.75-$7.90 from $7.55-$7.70; adjusted free cash flow outlook now $1.0B-$1.5B.
Announced $1.1B cash acquisition of Integrated Oncology Network, adding 100+ providers across 10 states.
Completed $375M accelerated share repurchase in October; Global Medical Products segment profit fell to $8M from $12M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.